About Novalek Pharmaceutical Private Limited
Data last updated:
Novalek Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2006PTC120839. Its GSTIN is 36AACCN3244Q1Z3 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Jyoti Loomba and Sanjay Kumar Prabhakar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Nsl Centrum Plot No.S – 1 Sy No: 1043 & 1048, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.15 Lakh. For the same year it recorded a net profit of ₹4.61 Lakh (net margin 50.4%) and EBITDA of ₹4.62 Lakh (EBITDA margin 50.5%).
The company is associated with 1 brand: Novalek Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website novalekpharma.com.
Company details
CIN history
Novalek Pharmaceutical has one previous CIN (Corporate Identification Number): U24231DL2006PTC144561. The current CIN is U24231TG2006PTC120839, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2006PTC120839 | Current |
| U24231DL2006PTC144561 | Previous |
Contact details
Novalek Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana. Its website is novalekpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3rd Floor Nsl Centrum Plot No.S – 1 Sy No: 1043 & 1048, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Novalek Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Novalek Pharmaceutical operates one associated brand: Novalek Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical development, production, and marketing of generic and branded drugs in India. | novalekpharma.com |
Financials of Novalek Pharmaceutical Private Limited
FY 2025 filings availableNovalek Pharmaceutical Private Limited reported revenue of ₹9.15 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 50.5% | ||||
| Net Profit Margin | 50.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novalek Pharmaceutical Private Limited, buy the company report.
Board of directors of Novalek Pharmaceutical Private Limited
Novalek Pharmaceutical has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti Loomba Also directs: Jodas Expoim Private Limited, Jodas Consumer Care Private Limited, Arjunya Consumer Care Private Limited and 1 more | Director | 01 Oct 2012 | 14 Years 1 Months | Current |
| Sanjay Kumar Prabhakar Also directs: Novalek Laboratories LLP, Bioexa Lifesciences Private Limited | Director | 09 Jan 2006 | 20 Years 10 Months | Current |
| Shashi Shanker Parsad Singh Also directs: Jodas Expoim Private Limited, Jodas Consumer Care Private Limited | Director | 01 Oct 2012 | 14 Years 1 Months | Current |
| Anu Kumari Also directs: Anu Chauhan Fashions (OPC) Private Limited | Director | 09 Jan 2006 | 20 Years 10 Months | Current |
Auditor
Novalek Pharmaceutical Private Limited is audited by RRK & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RRK & ASSOCIATES | FY 2023 | 210777 |
Shareholding
The shareholding of Novalek Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Novalek Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Novalek Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novalek Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novalek Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCN3244Q1Z3 | Telangana | Active | 16 Dec 2019 |
To see the full GST registrations and return filing status of Novalek Pharmaceutical Private Limited, buy the company report.
Recent activity
Novalek Pharmaceutical Private Limited has 6 board changes on record since 2006: 4 appointments and 2 cessations. The latest: Jyoti Loomba ceased to be Additional Director on 25 Sep 2015.
Frequently asked questions
Novalek Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2006 (20+ years old) and is registered under CIN U24231TG2006PTC120839.
Novalek Pharmaceutical has 4 current directors:
- Jyoti Loomba - Director
- Sanjay Kumar Prabhakar - Director
- Shashi Shanker Parsad Singh - Director
- Anu Kumari - Director
The latest financial statements of Novalek Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Novalek Pharmaceutical is 36AACCN3244Q1Z3, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Novalek Pharmaceutical is U24231TG2006PTC120839. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novalek Pharmaceutical was incorporated on 09 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
Jyoti Loomba ceased to be Additional Director on 25 Sep 2015. Shashi Shanker Parsad Singh ceased to be Additional Director on 25 Sep 2015. Jyoti Loomba was appointed as Director on 01 Oct 2012. Novalek Pharmaceutical has 6 board changes on record in total.
Novalek Pharmaceutical can be reached through the website novalekpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Novalek Pharmaceutical is at 3rd Floor Nsl Centrum Plot No.S – 1 Sy No: 1043 & 1048, Hyderabad, Telangana, India – 500072.
Novalek Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
